Eastman Chemical (EMN) EBIAT (2016 - 2025)
Eastman Chemical (EMN) has disclosed EBIAT for 17 consecutive years, with $106.0 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, EBIAT fell 67.98% year-over-year to $106.0 million, compared with a TTM value of $475.0 million through Dec 2025, down 47.69%, and an annual FY2025 reading of $475.0 million, down 47.69% over the prior year.
- EBIAT was $106.0 million for Q4 2025 at Eastman Chemical, up from $46.0 million in the prior quarter.
- Across five years, EBIAT topped out at $378.0 million in Q4 2021 and bottomed at -$146.0 million in Q2 2021.
- Average EBIAT over 5 years is $196.6 million, with a median of $206.0 million recorded in 2024.
- The sharpest move saw EBIAT crashed 640.74% in 2021, then skyrocketed 30800.0% in 2023.
- Year by year, EBIAT stood at $378.0 million in 2021, then crashed by 99.74% to $1.0 million in 2022, then surged by 30800.0% to $309.0 million in 2023, then increased by 7.12% to $331.0 million in 2024, then tumbled by 67.98% to $106.0 million in 2025.
- Business Quant data shows EBIAT for EMN at $106.0 million in Q4 2025, $46.0 million in Q3 2025, and $141.0 million in Q2 2025.